CD157 is also a promising marker for disease monitoring in B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) where high CD157 expression on malignant cells discriminates them from CD157-negative normal B cells from the same patient18. This evidence concerns the gene BST1 and acute lymphoblastic leukemia.